Related Experiment Video
Updated: Apr 5, 2026
Organotypic Hippocampal Slice Cultures As a Model to Study Neuroprotection and Invasiveness of Tumor Cells
Published on: August 27, 2017
[Neuroprotective mechanisms of cannabinoids in brain ischemia and neurodegenerative disorders]
Abstract:
One of the most important causes of morbidity and mortality is neurologic dysfunction; its high incidence has led to an intense research of the mechanisms that protect the central nervous system from hypoxia and ischemia. The mayor challenge is to block the biochemical events leading to neuronal death. This may be achieved by neuroprotective mechanisms that avoid the metabolic and immunologic cascades that follow a neurological damage. When it occurs, several pathophysiological events develop including cytokine release, oxidative stress and excitotoxicity. Neuroprotective effects of cannabinoids to all those mechanisms have been reported in animal models of brain ischemia, excitotoxicity, brain trauma and neurodegenerative disorders. Some endocannabinoid analogs are being tested in clinical studies (I-III phase) for acute disorders involving neuronal death (brain trauma and ischemia). The study of the cannabinoid system may allow the discovery of effective neuroprotective drugs for the treatment of neurological disorders.
Insights
Cannabinoids show neuroprotective effects against brain damage by blocking damaging biochemical events. Research into the cannabinoid system may lead to new treatments for neurological disorders.
Area of Science:
- Neuroscience
- Pharmacology
Context:
- Neurologic dysfunction is a major cause of death and disability.
- Protecting the central nervous system (CNS) from hypoxia and ischemia is a key research area.
- Neuronal death results from complex biochemical events following neurological damage.
Purpose:
- To investigate the neuroprotective mechanisms of cannabinoids.
- To explore the potential of targeting the cannabinoid system for treating neurological disorders.
Summary:
- Cannabinoids demonstrate neuroprotective effects in animal models of brain ischemia, excitotoxicity, brain trauma, and neurodegenerative diseases.
- These effects are attributed to their ability to counteract key pathophysiological events like cytokine release, oxidative stress, and excitotoxicity.
- Endocannabinoid analogs are progressing through clinical trials for acute neurological conditions such as brain trauma and ischemia.
Impact:
- The study of the cannabinoid system holds promise for developing novel neuroprotective drugs.
- This research could lead to effective treatments for a range of debilitating neurological disorders.
- Understanding these mechanisms is crucial for advancing therapeutic strategies against neuronal death.
Related Concept Videos
01:24CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
00:49The Blood-brain Barrier
01:15Neurogenesis and Regeneration of Nervous Tissue
01:21Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Two synthetic agonists of THC,...